Surgery Websites
Transplant Surgery »  Meet the Team »  Division Chief »  Chris E. Freise, M.D.
Chris E. Freise, M.D.

Chris E. Freise, M.D.

Professor & Interim Division Chief
Division of Transplant Surgery

Contact Information

(415) 353-1888 Clinical, Liver
(415) 353-1551 Clinical, Kidney and Pancreas
(415) 353-9321 Academic
Chris.Freise@ucsf.edu
Open Popup
  • University of Minnesota, B.A., Chemistry, 1978-82
  • University of Minnesota, M.D., 1982-86
  • University of Minnesota, Intern, Surgery, 1986-87
  • University of Minnesota, Resident, Surgery, 1987-89
  • University of Minnesota, Resident, Surgery, 1992-93
  • University of Minnesota, Chief Resident, Surgery, 1993-94
  • University of California, San Francisco, Research Fellow, Surgery, 1989-92
  • University of California, San Francisco, Clinical Fellow, Transplant Surgery, 1994-96
  • American Board of Surgery, 1995
  • Bile Duct Injuries
  • Bile Duct Strictures
  • Cholangiocarcinoma (Bile Duct Cancer)
  • Choledochal Cyst Disease
  • Dialysis Access
  • Expanded Criteria Donor Kidney Transplantation
  • Fulminant Hepatic Failure
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Intestinal Transplantation and Rehabilitation
  • Kidney and LIver Transplantation in HIV Patients
  • Kidney Auto-transplantation
  • Kidney Transplantation
  • Laparoscopic Donor Nephrectomy
  • Laparoscopic Kidney and Liver Surgery
  • Liver Transplantation
  • Living Donor Kidney Transplantation
  • Living Donor Liver Transplantation
  • Pancreas Transplantation
  • Pediatric Kidney Transplantation
  • Pediatric Liver Transplantation
  • Polycystic Kidney Disease
  • Polycystic Liver Disease
  • Portal Hypertension
  • Surgical Shunts
  • Delivery of Immunosuppressive Agents to Organ Allografts
  • Improvement Organ Function in Deceased Donors
  • Ischemia Reperfusion Injury

Chris E. Freise, M.D. received his medical degree from the University of Minnesota where he also did his internship and residency in General Surgery. He later completed a  transplantation fellowship at UCSF.   

He is a member of numerous professional organizations including The Transplantation Society, the International Pancreas and Islet Transplant Association, the Transplant Infectious Disease Society, the American Hepato-Pancreato-Billiary Association and the Society of University Surgeons. In addition, he recently served as the Medical Director for California Transplant Donor Network. He is also the Associate Counselor for UNOS Region 5, and a member of the UNOS Membership and Professional Standards Committee.

Dr. Freise has authored more than eighty (80) in peer-reviewed publications and five (5) book chapters. He is an accomplished researcher and clinical educator. Dr. Freise is also a frequent invited lecturer to national and international and conferences in the field.         

Dr. Friese's basic science research focuses on the delivery of immunosuppressive agents to organ allografts, ischemia reperfusion injury, and methods to improve organ function in deceased donors. His clinical research includes  a multicenter trial investigating donor and recipient outcomes following living donor liver transplantation.

Data provided by UCSF Profiles, powered by CTSI
  • Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients
    Sponsor:
    Sponsor ID:
    Funding Period:
    Feb 2010
    -
    Aug 2015
    Principal Investigator
  • Living Donor Liver Transplant :Short &Long-Term Impact on Donors and Recipients
    Sponsor:
    Sponsor ID:
    Funding Period:
    Sep 2002
    -
    Aug 2015
    Principal Investigator
MOST RECENT PUBLICATIONS FROM A TOTAL OF 119
Data provided by UCSF Profiles, powered by CTSI
  1. Wisel S, Thiessen C, Day R, Belin J, Syed S, Hirose R, Ascher N, Roberts J, Freise C. Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement". Am J Transplant. 2020 Dec 04. View in PubMed
  2. Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL. Opioid use prior to liver transplant is associated with increased risk of death after transplant. Am J Surg. 2020 Nov 20. View in PubMed
  3. Atreya CE, Collisson EA, Park M, Grenert JP, Behr SC, Gonzalez A, Chou J, Maisel S, Friedlander TW, Freise CE, Shoji J, Semrad TJ, Van Ziffle J, Chin-Hong P. Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients. J Natl Compr Canc Netw. 2020 11; 18(11):1446-1452. View in PubMed
  4. Gomez A, Wisneski AD, Luu HY, Hirose K, Roberts JP, Hirose R, Freise CE, Nakakura EK, Corvera CU. Contemporary Management of Hepatic Cyst Disease: Techniques and Outcomes at a Tertiary Hepatobiliary Center. J Gastrointest Surg. 2020 Oct 20. View in PubMed
  5. Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P. Treatment of immunocompromised COVID-19 patients with convalescent plasma. Transpl Infect Dis. 2020 Sep 29; e13477. View in PubMed
  6. View All Publications

 

Site Directory
    X